Legionella testing includes testing of water samples collected from places like hospitals, hotels and others, where Legionella bacteria may thrive and spread. Legionella causes Legionnaires' disease, which is a serious type of pneumonia. Legionella bacteria are commonly found in water and can grow in human-made building water systems like cooling towers, decorative fountains, hot tubs and plumbing systems. Legionella testing helps identify the presence of the bacteria and helps take necessary measures to prevent outbreaks.
The global Legionella testing Market is estimated to be valued at US$ 1,864.07 Mn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics
According to the report, one of the major drivers boosting the growth of the Legionella testing market is the increasing incidence of waterborne diseases. Legionnaires' disease as well as other waterborne diseases are on the rise globally due to factors such as aging infrastructure and rising global temperatures due to climate change which provide conducive environments for the growth of waterborne pathogens. According to the World Health Organization (WHO), Legionella causes around 10,000 deaths every year in the United States. WHO also estimates that there are around 500,000 people affected by Legionella worldwide annually. Rising cases of Legionella infections are expected to drive more testing to detect and treat outbreaks, thus propelling the Legionella testing market growth over the forecast period.
SWOT Analysis
Strength: Legionella testing kits are easy to use with quick turnaround time for results, which allows for prompt treatment. Rapid diagnostic tests can provide preliminary results within 15 minutes. Polymerase chain reaction (PCR) tests offer high sensitivity and specificity for legionella detection.
Weakness: Sample collection and transportation requirements can be complex for Legionella testing. Specialized training is required for technicians to perform tests properly. False negatives may occur if samples are improperly collected or transported.
Opportunity: Growing elderly population is more susceptible to legionella infection. Increasing awareness about legionellosis and availability of reimbursement is expanding the testing market. Point of care testing is gaining popularity due to immediate results.
Threats: Low disease awareness in developing nations limits market growth. Strict quality control and regulatory approvals pose challenges for new entrants. Alternative treatment options threaten overall testing demand. Laboratory budget cuts can reduce routine legionella testing.
Key Takeaways
The global Legionella testing market is expected to witness high growth. Advancements in molecular diagnostic techniques are permitting the development of rapid, sensitive, and easy-to-use Legionella testing solutions. This is expected to boost the adoption of Legionella testing, thereby driving market growth. The growing regulatory emphasis on preventing hospital-acquired infections will further promote the adoption of Legionella testing.
Regional analysis: North America currently dominates the global Legionella testing market due to supportive regulatory guidelines and the presence of major players. However, the Asia Pacific region is expected to grow at the fastest pace over the forecast period. This can be attributed to growing healthcare industry, increasing healthcare expenditure, and rising awareness regarding healthcare-associated infections.
Key players: Key players operating in the Legionella testing market are Boston Scientific Corporation, Argon Medical Devices, Inc., Becton, Dickinson and Company, Cook Medical, B. Braun Melsungen AG, Medtronic Plc., Novo Nordisk A/S, SERAG-WIESSNER GmbH & Co., Smithâ€TMs Medical, Terumo Corporation, Stryker Corporation, and NIPRO Medical Corporation.
The Legionella Testing Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Legionella Testing Market Research Report" by requesting FREE Sample Copy athttps://www.valuemarketresearch.com/contact/legionella-testing-market/download-sampleMarket DynamicsThe global legionella testing market is growing at a rapid pace due to increasing cases of legionellosis; and growing awareness about the preventive measurement against the waterborne diseases.
The other prominent factors that are driving the market include favorable government policies and growing adoption for rapid, advanced diagnostic tools.
COVID-19 pandemic is anticipated to boost the global testing market owing as the global focus is on the enhancement of the healthcare system and the development of rapid testing kits.
SARS-COV-2 also causes viral pneumonia; hence to detect and diagnose the cause of pneumonia, the global Legionella testing market is expected to prosper during the pandemic.
